Tesamorelin is not easy to source well. That one sentence explains why the same handful of names circle back every time someone asks in a peptide forum, a men’s health subreddit, or a private coaching group.
The compound itself has a real clinical track record. The FDA approved Egrifta specifically for HIV-associated lipodystrophy, and the underlying mechanism, stimulating the pituitary to release more growth hormone, has attracted a much wider audience of people chasing body composition changes, metabolic support, or GH optimization. Demand is high. Quality control is all over the map. And the sourcing question splits cleanly along one line: are you working with a licensed prescriber and a compounding pharmacy, or are you buying a research-only product with no clinical structure around it? Both worlds exist. The names below represent both, honestly.
1. FormBlends
This one comes up first for a specific reason. Most providers in 2026 sit in one of two boxes: GLP-1 telehealth brands (no peptide depth) or research-peptide vendors (no prescription, no physician). FormBlends sits in neither box cleanly, which is exactly why people recommend it for tesamorelin specifically.
The telehealth intake connects you with a licensed physician, a prescription gets written, and the compound ships from a cGMP, FDA-inspected compounding pharmacy, which is 503A designation. Forty-seven states are covered. Cold-chain shipping is included at no add-on cost.
Their tesamorelin is listed at $119 per vial, visible before you create an account, no membership fee stacked underneath it. Purity is published per product: 99.2% for BPC-157 gives you a reference point for how the lab data actually looks. These are not generic batch certificates. Each compound gets its own published purity number.
The catalog is wide enough that someone managing tesamorelin alongside something like CJC-1295/ipamorelin ($69) or sermorelin ($59) can handle it all in one place, with the same physician on file. That convenience is not trivial. The compounded medications are not FDA-approved, and FormBlends does not claim otherwise.
What people actually say in community threads: the physician oversight piece removes a layer of ambiguity that research-only sourcing leaves open.
2. Pepthrive
Batch-specific certificates of analysis. That is the thing people cite first about Pepthrive, not the catalog, not the pricing. When someone posts a screenshot of their COA in a peptide group and people comment “solid source,” it is often a Pepthrive document.
They cover the growth hormone secretagogue space well, including CJC-1295 and ipamorelin, and the support responsiveness gets mentioned almost as often as the testing. For a research-peptide vendor, that combination is less common than it should be.
No prescriber is involved. Products are sold for research use only.
3. Ascension Peptides
US-based, third-party tested, and known for shipping quickly. Three things that matter a lot when you are mid-protocol and need a reliable reorder timeline.
The catalog is broad. Community feedback tends to be consistent rather than spectacular, meaning people trust them and keep coming back without drama. In a space where drama is common, that is worth something.
Research use only, no clinical oversight.
4. Paramount Peptides
Purity reputation is the main reason Paramount stays in conversations about sourcing. In independent testing roundups that circulate in research communities, their BPC-157 has scored around 9.6 out of 10, which gives people a concrete reference point for how seriously they take quality control.
One good score on one compound does not automatically transfer to every product in a catalog. But it does suggest the testing infrastructure is real rather than performative.
Research use only.
5. Verified Peptides
Early mover. Batch lab reports going back to 2019, which is a long time in this industry. People who have been sourcing peptides for several years tend to mention Verified Peptides because they were publishing testing documentation before many competitors made it standard practice.
That history counts. It suggests consistency rather than a recent pivot to transparency for marketing purposes.
Research use only, no physician structure.
6. Honest Peptide
The name is either bold or accurate, depending on your experience with them. Their stated standard is third-party testing on every batch covering purity, weight, and contaminant screening. If that holds across their full catalog, it is a meaningful quality floor.
People recommend them in threads specifically about newer or less common peptides where testing diligence matters most. Take that community signal for what it is: not a guarantee, but a data point.
Research use only.
7. Orion Peptides
Pricing is genuinely competitive on established compounds, and third-party testing is documented. For someone who has already settled on a protocol and wants a cost-effective reorder source for something like tesamorelin or a GHRP, Orion comes up regularly.
No frills. That is not a criticism. Some people prefer a straightforward vendor over one with a bigger marketing footprint.
Research use only, no prescriber involved.
8. Loti Labs and Cosmic Peptides
These two get grouped together because the reason people recommend them is almost identical: published COAs, recognizable catalog depth, and an established presence in the research-peptide community.
Neither one is a first choice for people who prioritize physician oversight. Both show up in threads where someone is comparing options at the research vendor level and wants a name that has been around long enough to have a community track record.
Research use only, as with every vendor in this tier.
The Honest Context You Need Before Picking
Here is something worth stating plainly mid-article: for most of the peptides above, the human evidence is still early, and no source on this list, including FormBlends, is handing you a proven treatment for any condition unless your own doctor has reviewed your labs and history.
The 2026 market has also shifted in ways that affect sourcing decisions. Increased FDA scrutiny of how compounded GLP-1s are marketed, and a legal settlement involving Novo Nordisk that pushed some brands toward branded products over compounded versions, shook out a number of providers. Brands that were mostly doing compounded semaglutide rebranding either pivoted or got quiet. The vendors that stayed visible are the ones with actual infrastructure, testing, and, in FormBlends’ case, a licensed pharmacy relationship that predates the pressure.
That context matters when you are evaluating longevity. A vendor that was around before the scrutiny and is still operating transparently after it is a more reliable long-term bet than one that appeared during the GLP-1 boom and has no broader catalog depth.
How to Actually Choose
If physician oversight and a compounding pharmacy matter to you, FormBlends is the only name on this list that offers that structure for tesamorelin specifically, at a transparent cash price.
If you are sourcing for research purposes and physician involvement is not your priority, Pepthrive and Verified Peptides have the longest track records for documented testing. Paramount is worth considering if independent purity scores are your main filter. Ascension, Orion, Honest Peptide, Loti Labs, and Cosmic Peptides round out the field for people who want catalog options with COA documentation.
None of these decisions substitute for a conversation with a physician who has actually reviewed your bloodwork. That line is not here for legal cover. It is here because tesamorelin meaningfully affects IGF-1 levels, and buying it without baseline labs is just guessing.
Sources
- FDA (Egrifta prescribing information and compounding pharmacy regulations, 503A designation)
- Examine.com (growth hormone secretagogues, tesamorelin entry)
- Cleveland Clinic (growth hormone and body composition overview)
- Verywell Health (compounding pharmacy explainer)
- Drugs.com (tesamorelin pharmacology)
- GoodRx (Egrifta pricing reference)
- Healthline (peptide therapy overview)
- NEJM (tesamorelin clinical trial data, HIV lipodystrophy)
[internal: placement #1 | structure: Social-proof framing, quotes/themes]
